VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Coloplast A/S vs MSCI Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Coloplast A/S
COLOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Coloplast A/S's moat claims, evidence, and risks.
View COLOB analysisMSCI Inc.
MSCI · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Coloplast A/S leads (77 / 100 vs 76 / 100 for MSCI Inc.).
- Segment focus: Coloplast A/S has 5 segments (35.5% in Ostomy Care); MSCI Inc. has 4 segments (55.9% in Index).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Coloplast A/S has 7 moat types across 3 domains; MSCI Inc. has 4 across 3.
Primary market context
Coloplast A/S
Ostomy Care
Ostomy care products (bags, plates, supporting products)
Global
Healthcare providers and distributors; end-users are ostomy patients
Medical device manufacturer (disposable consumables)
35.5%
MSCI Inc.
Index
Investment indexes and index licensing
Global
Institutional investors and asset managers
Index provider / benchmark administrator
55.9%
Side-by-side metrics
Moat coverage
Shared moat types
Coloplast A/S strengths
MSCI Inc. strengths
Segment mix
Coloplast A/S segments
Full profile >Ostomy Care
Oligopoly
Continence Care
Oligopoly
Voice & Respiratory Care
Oligopoly
Wound & Tissue Repair
Competitive
Interventional Urology
Oligopoly
MSCI Inc. segments
Full profile >Index
Oligopoly
Analytics
Oligopoly
Sustainability and Climate
Competitive
Private Assets
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.